The American Medical Association’s October clinical-AI liability brief argues that responsibility should follow each party’s authority, information and ability to prevent harm. It separates the roles of developers, deploying organizations and physicians, rather than treating physician review as a universal backstop. This is an advocacy framework, not a new law or a decision about a particular claim. The AMA’s overview
Its practical question is whether the person expected to catch an error could actually see and act on it.
Review depends on what reaches the reviewer
The five-page issue brief gives examples involving a triage decision hidden behind a patient queue and an apparently plausible summary based on incomplete upstream information. In each, the existence of a physician later in the pathway does not mean the physician had access to the earlier decision or its inputs.
That distinction is useful beyond the phrase “human in the loop.” A workflow can contain a person while still leaving that person without the information, time or authority needed for meaningful oversight.
The brief applies its argument to clinical workflows. It explicitly leaves patient-directed AI outside clinician-led care beyond this paper’s scope.
Shared responsibility does not make the roles interchangeable
The AMA assigns developers responsibility for risks in what they build and deployers responsibility for the circumstances in which systems are used. It also describes continuing responsibilities after a tool enters service.
These are the organization’s proposed principles. They do not determine how a court would allocate liability, whether a particular contract is enforceable or what another jurisdiction requires.
The distinction also helps explain why selecting a product and responding to one of its outputs are different decisions. A clinician may encounter a result after choices about procurement, interface configuration and monitoring have already been made elsewhere.
Patient remedies belong in the same discussion
The brief connects protections for appropriate physician reliance with meaningful routes for patients harmed by actionable failures. Its framework is not an argument that shared involvement should leave nobody accountable.
For a professional reader, the document offers a way to describe where control sits. Applying that description to an actual system or dispute would require the relevant evidence and qualified advice. The source supports an account of the AMA’s position, rather than an assurance that a particular deployment is safe or legally compliant.